SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013308
Filing Date
2018-05-14
Accepted
2018-05-14 07:36:32
Documents
44
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q1 evok-10q_20180331.htm 10-Q 652316
2 EX-10.1 evok-ex101_336.htm EX-10.1 37706
3 EX-31.1 evok-ex311_6.htm EX-31.1 9578
4 EX-31.2 evok-ex312_9.htm EX-31.2 9860
5 EX-32.1 evok-ex321_8.htm EX-32.1 5020
6 EX-32.2 evok-ex322_7.htm EX-32.2 5237
  Complete submission text file 0001564590-18-013308.txt   2532951

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT evok-20180331.xml EX-101.INS 412426
8 XBRL TAXONOMY EXTENSION SCHEMA evok-20180331.xsd EX-101.SCH 30778
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20180331_cal.xml EX-101.CAL 15902
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20180331_def.xml EX-101.DEF 89107
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20180331_lab.xml EX-101.LAB 204343
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20180331_pre.xml EX-101.PRE 152863
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 18828684
SIC: 2834 Pharmaceutical Preparations